Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout

Also: Foundation Models & Drug‑Discovery Economics, Structuring Meaning for AI with Ontologies, & Emerging Startups

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

In today’s highlights: Toronto startup launches with $11M and a robotic formulation platform—Insilico Medicine files for a third IPO, the UK trains a generative AI on records from 57 million patients—Recursion cu…